Compare · AXP vs CELZ
AXP vs CELZ
Side-by-side comparison of American Express Company (AXP) and Creative Medical Technology Holdings Inc. (CELZ): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AXP and CELZ operate in Finance: Consumer Services (Finance), so they compete in similar markets.
- AXP is the larger of the two at $222.55B, about 57929.2x CELZ ($3.8M).
- Over the past year, AXP is up 5.9% and CELZ is down 71.5% - AXP leads by 77.3 points.
- AXP has been more active in the news (21 items in the past 4 weeks vs 7 for CELZ).
- AXP has more recent analyst coverage (25 ratings vs 1 for CELZ).
- Company
- American Express Company
- Creative Medical Technology Holdings Inc.
- Price
- $326.19-4.29%
- $0.81-0.47%
- Market cap
- $222.55B
- $3.8M
- 1M return
- -4.79%
- -59.90%
- 1Y return
- +5.85%
- -71.48%
- Industry
- Finance: Consumer Services
- Finance: Consumer Services
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 21
- 7
- Recent ratings
- 25
- 1
American Express Company
American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products and services also comprise merchant acquisition and processing, servicing and settlement, point-of-sale marketing, and information products and services for merchants; and fraud prevention services, as well as the design and operation of customer loyalty programs. It sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through mobile and online applications, third-party vendors and business partners, direct mail, telephone, in-house sales teams, and direct response advertising. American Express Company was founded in 1850 and is headquartered in New York, New York.
Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
Latest AXP
- SEC Form 10-Q filed by American Express Company
- American Express Company filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- American Express Reports Second-Quarter 2026 Financial Results
- American Express and ALL Accor Expand the Power of Membership with New Global Partnership
- More Ways for Canadians to Travel, Earn and Be Rewarded: American Express and ALL Accor Announce Global Partnership
- American Express Launches Intelligent Capabilities to Help Streamline Buyer and Supplier Payments
- Bottomline and American Express Partner to Expand B2B Payment Connectivity Through Paymode
- American Express Declares Dividend on Series D Preferred Stock
- American Express Company filed SEC Form 8-K: Regulation FD Disclosure
- American Express upgraded by Analyst with a new price target
Latest CELZ
- SEC Form S-3 filed by Creative Medical Technology Holdings Inc.
- SEC Form DEF 14A filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- SEC Form PRE 14A filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Issues Mid-Year Update
- Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
- SEC Form RW filed by Creative Medical Technology Holdings Inc.
- Amendment: SEC Form S-1/A filed by Creative Medical Technology Holdings Inc.
- SEC Form S-1 filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain